Asuragen Quantidex Pan Cancer Kit
Asuragen has launched the Quantidex Pan Cancer Kit, a next-generation sequencing oncology panel of 21 genes relevant to a diverse set of human cancers. The kit integrates reagents, controls, and a novel bioinformatics suite and is optimized to interrogate difficult sample types such as formalin-fixed, paraffin-embedded and fine-needle aspiration tissues, Asuragen said. More specifically, the kit contains reagents for pre-analytical DNA QC, sample quantification, multiplex PCR enrichment, dual-index barcoding, and library purification and quantification, the company said. The product is currently for research use only, Asuragen noted.